Qurient Co., Ltd. (KOSDAQ: A115180)
Health Care · Biotechnology · KR
₩22,350.00
-9.70% today · +14.6% 1Y
Qurient Co., Ltd. (KOSDAQ: A115180) operates in the Biotechnology industry within the Health Care sector. The company is valued at $676.80M.
Over the last twelve months the share price has gained 14.6%, trading between 14.33K and 62.90K.
Tweenvest scores Qurient Co., Ltd. across four factors: quality 46/100, value 54/100. Its strongest factor is value.
A115180 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $676.80M
- Revenue (TTM)
- $4.56M
- P/E
- —
- EPS
- -1,057.38
- Dividend yield
- —
- Beta (5Y)
- 0.45
- 52-week high
- ₩62,900.00
- 52-week low
- ₩14,330.00
- Avg volume (3M)
- —
- Shares outstanding
- 40.71M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Nuvectis Pharma, Inc.NasdaqCM: NVCT | $688.12M | $19.69 | -6.77% |
| Olema Pharmaceuticals, Inc.NasdaqGS: OLMA | $684.23M | $7.36 | -5.88% |
| Design Therapeutics, Inc.NasdaqGS: DSGN | $682.77M | $10.91 | -6.35% |
| Aura Biosciences, Inc.NasdaqGM: AURA | $678.23M | $6.54 | 0.00% |
| Sunmax Biotechnology Co., Ltd.TPEX: 4728 | $674.51M | NT$396.00 | +0.38% |
| Faeth Therapeutics, Inc.NasdaqCM: FTH | $672.63M | $23.25 | -10.68% |
| Abbisko Cayman LimitedSEHK: 2256 | $665.94M | HK$7.89 | -9.83% |
| Beijing Bohui Innovation Biotechnology Group Co., Ltd.SZSE: 300318 | $646.39M | CN¥5.30 | +1.34% |
Figures last refreshed Oct 11, 2026.